April 28 (Reuters) – Centene on Tuesday raised its 2026 adjusted profit forecast after a quarterly earning beat, as the health insurer expects to gain from its efforts to rein in elevated costs that have pummeled the sector for more than two years.
The company also raised its annual revenue forecast, sending its shares up 1.24% to $44.04 in premarket trading.
The raised forecast from Centene follows similar moves from larger peers UnitedHealth and Elevance, adding to investors relief.
“We continue to make tangible progress in our margin recovery efforts,” said Chief Executive Officer Sarah London.
Centene’s medical loss ratio, the percentage of premiums spent on medical care, was 87.3% in the first quarter. Analysts had expected the company to report a ratio of 89.42%, according to LSEG data.
Besides high costs due to a mismatch in reimbursement rates offered to health insurers and demand for healthcare, the industry has been hit by U.S. President Donald Trump’s tax and budget bill that will decrease funding for Medicaid plans for low-income Americans.
The expiration of COVID-pandemic-expanded subsidies has also also resulted in a sicker member pool under Obamacare plans.
Americans face high healthcare costs as monthly premiums for many soared due to the expiration of the health insurance subsidies.
The company now sees 2026 adjusted profit above $3.40, compared with its previous expectations of more than $3. Analysts expected a profit of $3.02 per share.
On an adjusted basis, the company earned a profit of $3.37 per share in the reported quarter, surpassing estimate of $2.13.
(Reporting by Sriparna Roy and Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Comments